Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology

Vaccination programs with the current prophylactic HPV vaccines started in most countries around 2008 with introduction of the bivalent Cervarix HPV16/18 vaccine, rapidly followed by Gardasil (HPV6/11/16/18) and, finally, Gardasil 9 (HPV6/11/16/18/31/33/45/52/58), from 2015. Many studies have now co...

Descripción completa

Detalles Bibliográficos
Autor principal: Hampson, Ian N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029410/
https://www.ncbi.nlm.nih.gov/pubmed/35458487
http://dx.doi.org/10.3390/v14040757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029410/
https://www.ncbi.nlm.nih.gov/pubmed/35458487
http://dx.doi.org/10.3390/v14040757

Ejemplares similares